Indefinite Delivery Contract SPE2DU25D2234

The federal contract IDV award is a single award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999, has an ultimate completion date of December 31, 2036 and provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the United States Coast Guard, and the U.S. Naval Fleet.

The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The DLA intends to make multiple primary supplier awards for separate regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) as well as a single backup supplier award, to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The contract will be awarded on a lowest price technically acceptable basis, with the potential use of reverse auctions to determine the final distribution fees.